Bioactive polymers 54. Pharmacological properties of modified neomycin

J Biomater Appl. 1991 Jul;6(1):80-8. doi: 10.1177/088532829100600106.

Abstract

Modified neomycin prepared by the ionic coupling on xanthan with an activity of 380 UI/mg was characterized in regard to its in vitro and in vivo release rate and therapeutic action with artificial tear eluent. The dynamic system in vitro release showed that after 4 h, there appears a "zero-order" kinetic. Ophthalmic inserts were prepared from modified neomycin and they are used in treating bacterial conjunctivitis. Sterilization of the conjunctival sac is obtained 12 h after insert administration.

MeSH terms

  • Conjunctivitis, Bacterial / drug therapy*
  • Delayed-Action Preparations
  • Humans
  • Neomycin / chemistry*
  • Neomycin / pharmacology*
  • Staphylococcal Infections / drug therapy*

Substances

  • Delayed-Action Preparations
  • Neomycin